Vicente A. O.
- Country
- Spain
- Department
- Oncology
Research Overview
- Phase III Study Comparing FOLFOX Plus Panitumumab Followed by FOLFIRI Plus Bevacizumab Versus FOLFOX Plus Bevacizumab Followed by FOLFIRI Plus Panitumumab in Wild-Type RAS Metastatic Colorectal Cancer
- Sotorasib and Combination Therapy Versus Standard Chemotherapy in Treatment-Naïve Patients with KRAS p.G12C-Mutated Metastatic Colorectal Cancer
- Phase 3 Randomized Study of Perioperative Dostarlimab vs. Standard of Care in Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
Data & Insights
Has run more than one trial at 133 of 335 partner sites.
Specializations
Oncology
The investigator is involved in a broad oncology portfolio spanning breast cancer, colorectal cancer, pancreatic cancer, lung cancer, and gastrointestinal malignancies, with additional activity in ovarian cancer, endometrial cancer, and head and neck squamous cell carcinoma.
- Solid tumours
- Hematologic malignancies
- Metastatic disease
- Targeted cancer therapy
Research interests also extend to multiple myeloma, acute leukemias, lymphomas, sarcomas, and advanced tumor settings requiring novel systemic treatment strategies.
Breast and gynecologic oncology
Clinical trial involvement includes hormone receptor-positive breast cancer, HER2-negative breast cancer, triple-negative breast cancer, and HER2-positive breast cancer, along with ovarian cancer, endometrial cancer, and cervical cancer.
- Early breast cancer
- Metastatic breast cancer
- Gynecologic tumors
- Biomarker-driven therapy
The therapeutic focus includes treatment options across early, recurrent, and metastatic disease, with attention to adjuvant and endocrine-based approaches in breast cancer and precision strategies in gynecologic oncology.
Gastroenterology and hepatology
The investigator contributes to studies in inflammatory bowel disease, ulcerative colitis, Crohn’s disease, primary biliary cholangitis, non-alcoholic steatohepatitis, and advanced chronic liver disease.
- Autoimmune liver disease
- Cholestatic pruritus
- Cirrhosis
- Intestinal inflammation
Additional activity includes hepatic encephalopathy, pancreatic disorders, and gastroesophageal cancer, reflecting a strong interest in digestive and liver-related therapeutic innovation.
Cardiovascular and metabolic disease
Research activity includes atherosclerotic cardiovascular disease, coronary artery disease, acute ischemic stroke, hypercholesterolemia, hypertriglyceridemia, and familial hypercholesterolemia.
- Thrombotic risk
- Lipid disorders
- Stroke prevention
- Cardiometabolic risk reduction
The investigator is also involved in studies addressing heart failure risk, cardiovascular prevention, and vascular complications linked to systemic disease.
Immunology, transplantation, and rare disease
The clinical portfolio includes kidney transplantation, antibody-mediated rejection, IgA nephropathy, lupus nephritis, hemophilia, and sickle cell disease, alongside immune-mediated conditions such as atopic dermatitis, psoriasis, hidradenitis suppurativa, and vitiligo.
- Transplant immunology
- Bleeding disorders
- Autoimmune skin disease
- Rare inflammatory disorders
Additional interests include thyroid eye disease, age-related macular degeneration, and glaucoma, broadening the therapeutic scope into immune-mediated and specialty care areas.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.